J Natl Cancer Inst. 2009 July 15; 101(14): 1012–1018.
© The Author 2009. Published by Oxford University Press.
Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042
Affiliations of authors: Genetic and Molecular Epidemiology Group (RLM) and Human Genetics Group (JBe), Spanish National Cancer Research Centre [CNIO], Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras [CIBERER], Madrid, Spain (JBe); Department of Obstetrics and Gynecology (HN, TH), Department of Clinical Genetics (KA), and Department of Oncology (CB), Helsinki University Central Hospital, Helsinki, Finland; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain (JIA); Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain (MPZ); Department of Obstetrics and Gynecology (BB) and Institute of Human Genetics (CRB), University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group (BB) and Division of Cancer Epidemiology (JC-C), German Cancer Research Center [DKFZ]), Heidelberg, Germany; Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany (AMe); Department of Gynaecology and Obstetrics, Clinical Center University of Cologne, Köln, Germany (RKS); Institute for Cancer Studies (AC, IB, GE) and Academic Unit of Surgical Oncology (MWRR), Sheffield University Medical School, Sheffield, UK; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology (JLH, DRE) and Department of Pathology (MCS, LS), University of Melbourne, Victoria, Australia; Department of Laboratory Medicine and Pathology (FJC, XW) and Department of Health Sciences Research (JEO, ZF), Mayo Clinic, Rochester, MN; Department of Obstetrics and Gynaecology (TD, PS, PHi, NVB, MBe) and Department of Radiation Oncology (MBr, NVB), Hannover Medical School, Hannover, Germany; Department of Human Genetics (PD), Department of Pathology (PD), Department of Clinical Genetics (CJvA), and Department of Surgery (RAEMT), Leiden University Medical Centre, Leiden, the Netherlands; Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands (CS); Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden (PHa, KC); Human Genetics Laboratory, Genome Institute of Singapore, Singapore (JLi, YL); Department of Oncology (SA, AMD, MM, PDPP), Department of Public Health and Primary Care (PDPP), University of Cambridge, Cambridge, UK; Division of Genetics and Population Health (GC-T, JBee, ABS), Queensland Institute of Medical Research (AOCS), Brisbane, Australia; Peter MacCallum Cancer Center, Melbourne, Australia (kConFab, AOCS); N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus (NVB, NNA, IVZ); Department of Epidemiology, University of California Irvine, Irvine, CA (HA-C, AZ); Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany (HB, CJ); University of Tübingen, Tübingen, Germany (HB, CJ); Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany (Y-DK); Institute of Pathology, University of Bonn, Bonn, Germany (SHa); University Breast Center (PAF, RS, MWB) and Institute of Human Genetics (ABE), University Hospital Erlangen, Erlangen, Germany; Department of Gynecology and Obstetrics, David Geffen School of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA (PAF); Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia (GGG, GS, LB); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK (OF, NJ); Cancer Research UK Epidemiology and Genetics Group, London School of Hygiene and Tropical Medicine, London, UK (OF, IdSS, JP); Section of Cancer Genetics (CT, SHi, AR, NR), Institute of Cancer Research (JP), Sutton, Surrey, UK; Department of Clinical Biochemistry and Department of Breast Surgery, Herlev University Hospital, University of Copenhagen, Denmark (BGN, SEB, HF); Seoul National University College of Medicine, Seoul, Korea (DK, K-YY, D-YN); Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Kuopio (AMa, V-MK); Department of Oncology and Department of Pathology, University Hospital of Kuopio and Biocenter Kuopio, Kuopio, Finland (VK); Department of Oncology, Vaasa Central Hospital, Vaasa, Finland (VK); Division of Cancer Epidemiology and Genetics (MG-C, SC) and Hormonal and Reproductive Epidemiology Branch (LAB), National Cancer Institute, Rockville, MD; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland (JLis); Department of Gynecology and Obstetrics, Ulm Medical School, Ulm, Germany (SW-G); Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (C-YS, H-CW); Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan (J-CY); Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan (S-TC); Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia (MBe, EK); Department of Medical Genetics, Yakut Research Center of Russian Academy of Medical Sciences, Yakutsk, Russia (TN); Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (MKH, JM, RP, DFE)
Received November 28, 2008; Revised April 17, 2009; Accepted May 13, 2009.